Financial Gravity Asset Management, Inc. Eagle Pharmaceuticals, Inc. Transaction History

Financial Gravity Asset Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 28, 2020	SELL	$54.32 - $64.31 $13,417 - $15,884	-247 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$53.25 - $59.98 $18,477 - $20,813	-347 Reduced 58.42%	247 $14,000
Q2 2019 Jul 26, 2019	BUY	$46.61 - $58.45 $27,686 - $34,719	594 New	594 $33,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.